In lung cancer and nasopharyngeal carcinoma cells, only a low level of EMP2expression is detected, which can impact lung cancer cell metastasis and nasopharyngeal carcinoma cell death, indicating that EMP2 might present a tumor suppressor gene role in these two tumors. Here, EMP2 is linked to nasopharyngeal carcinoma.